VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
41 hedge funds and large institutions have $48.7M invested in Viracta Therapeutics, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
9% less funds holding
Funds holding: 45 → 41 (-4)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
Holders
41
Holding in Top 10
1
Calls
$925K
Puts
$51K
Top Buyers
| 1 | +$2.25M | |
| 2 | +$1.28M | |
| 3 | +$619K | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$605K |
| 5 |
BlackRock
New York
|
+$339K |
Top Sellers
| 1 | -$1.97M | |
| 2 | -$1.09M | |
| 3 | -$1.05M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$398K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$275K |